agelessrx tirzepatide vs. Semaglutide: Which Is Right for You? AgelessRx Adds Oral GLP-1 Drops

The follow-up period was limited to three years due to semaglutides recent approval

Overall prescribing rates (GLP-1 RA prescriptions per total prescriptions) in September 2025 remained stable relative to June 2025 (+4.6%)

This fleeting action is sufficient for meal-to-meal regulation but limits its therapeutic potential in its natural form

More on this topic Internal medicine physician Ni Jun from Raffles Hospital Shanghai said Chinese pharmaceutical firms may start launching generic or biosimilar versions, which would then put pressure on all companies to lower prices as patients and doctors weigh their options